RVL Pharmaceuticals plc 4 SEC Filings

Filed On	Filing
23 Oct 2023	Form 4: Harsaul Foundation, 10% owner Sold 9,363,760 shares ($432K) · Sold 4,758,899 shares ($148K)
23 Oct 2023	Form 4: Altchem Ltd, 10% owner and 1 other Sold 9,363,760 shares ($432K) · Sold 4,758,899 shares ($148K)
20 Oct 2023	Form 4: Harsaul Foundation, 10% owner Sold 3,421,537 shares ($221K)
20 Oct 2023	Form 4: Altchem Ltd, 10% owner and 1 other Sold 3,421,537 shares ($221K)
17 Aug 2023	Form 4: Avista Healthcare Partners GP, Ltd., 10% owner and 1 other Disposed of 23,730,864 shares (Other Transaction)
14 Aug 2023	Form 4: Lask Alisa, Director Gave up 12,000 shares to cover exercise price or tax ($5.88K)
11 Jul 2023	Form 4: DeBiasi Michael J., Director Received 40,000 shares as a grant or award
11 Jul 2023	Form 4: Cowan Gregory L, Director Received 40,000 shares as a grant or award
11 Jul 2023	Form 4: Lask Alisa, Director Received 40,000 shares as a grant or award
22 May 2023	Form 4: Schaub James, EVP and COO Gave up 5,577 shares to cover exercise price or tax ($4.85K)
22 May 2023	Form 4: Klein Christopher, General Counsel & Secretary Gave up 5,447 shares to cover exercise price or tax ($4.74K)
30 Jan 2023	Form 4: Burgstahler David F, Director Disposed of 1,032,995 shares (Other Transaction)
30 Jan 2023	Form 4: Venkataraman Sriram, Director Disposed of 1,032,995 shares (Other Transaction)
30 Jan 2023	Form 4: Avista Capital Partners Iii GP, L.p., 10% owner and 3 others Disposed of 1,032,995 shares (Other Transaction)
26 Jan 2023	Form 4: Klein Christopher, General Counsel & Secretary Gave up 9,608 shares to cover exercise price or tax ($12.1K)
26 Jan 2023	Form 4: Schaub James, EVP and COO Gave up 9,608 shares to cover exercise price or tax ($12.1K)
12 Aug 2022	Form 4: Lask Alisa, Director Received 75,000 shares as a grant or award
09 Aug 2022	Form 4: Schaub James, EVP and COO Bought 150,000 shares ($233K)
09 Aug 2022	Form 4: Markison Brian A, Director Bought 850,000 shares ($1.32M)
09 Aug 2022	Form 4: Burgstahler David F, Director Bought 8,000,000 shares ($12.4M)

Comments